# 1. Financial Performance ## A. Key Figures * **Revenue:** **₹993.8 Cr** Q4 FY26 (+0.9% QoQ CC) * **EBITDA Margin:** **24.6%** (+130 bps QoQ) * **Margin Drivers:** **+155 bps** Currency Tailwind · **+65 bps** Operating Leverage · **-90 bps** Salary Hikes ## B. Margin Improvement & Outlook * **Operational Efficiency:** Sequential margin expansion was driven by execution discipline, calibrated hiring, and pyramid management optimization. * **Sustainable Trajectory:** Management targets gradual, sustained margin accretion aligned with top-line growth rather than volatile spikes. * **Strategic Pricing:** No internal mandates exist to lower margins for deal wins; long-term profitability remains the primary corporate objective despite temporary investments in foundational deals. * **Future Headwinds:** While the mid-to-long-term outlook is positive, the company anticipates potential temporary shifts due to **scheduled salary hikes** and one-time events. ## C. Cost Structure & Currency * **Labor Costs:** A broad-based salary increase effective **January 1st** created a notable drag on quarterly profitability. * **Forex Impact:** Significant margin support was realized as various cross-currencies strengthened against the **INR**. --- # 2. Operating Segments ## A. Key Figures * **Transportation Revenue Growth:** **0.2%** QoQ CC * **Healthcare & Life Sciences Revenue Growth:** **-13.1%** QoQ CC * **Media & Communication Revenue Growth:** **5.6%** QoQ CC * **Transportation Revenue Mix:** **77%** from direct OEMs ## B. Transportation Performance * **Resilience Amid Volatility:** Achieved marginal growth in a flattish market, supported by strategic wins with APAC and US mobility players. * **Structural Shift to OEMs:** Revenue profile has stabilized with a vast majority of business now coming directly from OEMs rather than Tier 1 suppliers. * **AI & Pricing Stability:** Management reports no evidence of AI-led deflationary pressure or discount demands during contract renewals. * **Forward Outlook:** Despite recent headwinds, the vertical remains a primary driver with management targeting **double-digit growth** in the next fiscal year. ## C. Healthcare Recovery * **Unexpected Underperformance:** Revenue saw a sharp double-digit decline, failing to meet expectations that the previous quarter would serve as the cyclical bottom. * **Execution Delays:** Weakness was primarily driven by the conclusion of existing projects and timing issues regarding the signing of **two large deals**. ## D. Media & Communication * **Deal Ramp-up Momentum:** Robust sequential growth was fueled by the execution of previously won large deals and a new AdTech engagement. * **Strategic Engineering Wins:** Growth was bolstered by a significant Q4 deal involving the takeover and management of a customer's **legacy products**. * **Sector Headwinds:** Despite internal growth, the broader vertical faces volatility as telecom and streaming clients prioritize cost-cutting over innovation. --- # 3. Business Model & Execution ## A. Key Figures * **Utilization Rate:** **73%** Current level (Improved from <70%) * **Margin Sensitivity:** **25-30 bps** expansion per 1% utilization increase ## B. Fixed-Price Contracts & Execution * **Strategic Pivot:** Shifting toward longer-tenure (3-5 year) fixed-bid and platform-based delivery to enhance pricing power and internal efficiencies. * **Margin Dynamics:** Fixed-price models are driving margin expansion through a rationalized delivery pyramid, despite higher year-one costs from **rebadging and acquisition**. * **Risk Management:** Management is capping the shift to fixed-price models (avoiding levels of **70-80%**) to mitigate risks of revenue leakage and execution-related profitability dips. * **Value Proposition:** In ER&D, execution speed and value-add are prioritized over cost, with AI-led productivity becoming a core differentiator in project delivery. ## C. Offshore Delivery * **Global Expansion:** Established a dedicated offshore development center (ODC) for **Terumo Corporation** to drive MedTech innovation in cardiac and vascular solutions. * **Cost-Efficiency Demand:** Increasing traction in the transportation vertical as budget-constrained OEMs migrate complex engineering activities to best-cost countries. * **Operational Maturity:** High offshoring capability and a track record of remote, outcome-based delivery are reducing the need for client oversight. ## D. Utilization & Headcount Management * **Efficiency Targets:** Current utilization levels are being optimized with a target of reaching **80% to 82%** before re-initiating aggressive recruitment. * **Disciplined Hiring:** Headcount additions are strictly metered and restricted to specific, high-requirement roles rather than general capacity building. --- # 4. Technology & Innovation ## A. GenAI Adoption & Strategy * **Sector-Specific Adoption Bifurcation:** GenAI demand is highest in **Media and Telecom** for efficiency gains, while **Automotive and Healthcare** remain cautious due to safety-critical software processes and regulatory hurdles. * **Margin Enhancement Strategy:** Management is leveraging AI to drive sequential and YoY margin improvements on long-term deals, focusing on profitability over the full contract lifecycle. * **Standardized Bid Integration:** AI components are now integrated into all new project bids to systematically track and improve productivity and efficiency. * **Rational Market Dynamics:** The ER&D market remains rational as the specialized nature of engineering work prevents universal GenAI application across all contracts. ## B. DevStudio.ai & Domain-Specific AI * **Automotive SDLC Innovation:** The launch of **DevStudio.ai** addresses specific client concerns regarding cybersecurity and confidentiality in the automotive toolchain. * **Custom Tool Development:** The company is prioritizing custom AI tools over generic solutions for the Healthcare and Automotive sectors to mitigate risks of regulatory failure or physical harm. * **Value-Led Engineering:** Strategy emphasizes "value enhancement" over simple cost reduction, utilizing domain expertise to accelerate time-to-market and product quality. ## C. New Growth Areas & Infrastructure * **Telecom Infrastructure Lead:** Telcos are leading AI readiness by deploying the data centers and connectivity infrastructure required for GenAI applications. * **Aerospace & Defense Expansion:** Active scaling in the A&D vertical through collaborations with Indian organizations like **HAL** and the **Aeronautical Development Agency**, alongside global bidding. * **Energy Storage Incubation:** A new battery energy storage business has been incubated to support the high power demands of AI data centers and remote EV charging infrastructure. --- # 5. Strategic Initiatives ## A. Key Figures * **OEM Revenue Contribution:** **77%** of Transportation/Automotive vertical * **New Customer Contribution:** **2% to 2.5%** of quarterly revenue * **Target Deal Size:** **$50M to $100M** for consolidation contracts ## B. OEM Pivot & Market Expansion * **Successful Structural Shift:** The strategic pivot toward Original Equipment Manufacturers is now firmly established, with OEMs dominating the automotive revenue mix. * **Global Growth Footprint:** Transportation momentum is broad-based across the US, Europe, India, and Japan, with emerging engagement with **Chinese OEMs**. * **Tier 1 Retrenchment:** Management is navigating a shrinking Tier 1 supplier portfolio as OEMs internalize more responsibility, necessitating deeper entrenchment with select Tier 1 clients. ## C. Large Deal Consolidation * **Scale Capability:** The company has enhanced internal capabilities to pursue large-scale consolidation deals, targeting contracts up to **$100 million**. * **Strategic Pricing:** Management may selectively prioritize market share over margins on large deals with existing clients to block competitor entry, though no broad rate-cutting strategy exists. * **Key Wins:** Secured a significant multi-year deal with a global device OEM for its video and broadband portfolio. ## D. Customer Acquisition & Organic Growth * **Organic Pure-Play:** Growth remains entirely organic, a key differentiator from peers relying on inorganic acquisitions to drive top-line performance. * **Diversified Wins:** Recent acquisitions include the **Terumo ODC** in Healthcare, a new APAC automotive deal, and a significant Media and Communication win. * **New Vertical Entry:** Active investment is being channeled into the **manufacturing sector**, where the company has secured its initial customer wins. --- # 6. Client & Demand Risks ## A. Key Figures * **Revenue Leakage:** **10% to 15%** of quarterly revenue lost to project conclusions * **New Client Ramp-up:** **9 to 12 months** for significant financial impact * **Healthcare Deal Lag:** **6 months** longer than anticipated closing cycle ## B. Decision-Making Delays * **Healthcare Recovery:** Recent segment decline was driven by delayed deal closures; however, several contracts originally expected in Q4 have successfully closed in **early Q1**. * **OEM Buying Behavior:** Demand is currently anchored in value delivery and project support; management notes that customers remain cautious regarding **GenAI-based solutions** despite aggressive competitor pricing. * **Offshore Dynamics:** While the industry-wide shift toward offshoring continues, project ramp-ups remain sluggish following a challenging **12 to 18-month** macro environment. ## C. Revenue Leakage & Pipeline * **Replacement Pressure:** Significant quarterly revenue attrition from concluding projects necessitates a continuous high-volume pipeline to sustain top-line momentum. ## D. Industry Consolidation * **M&A Headwinds:** Sector-wide consolidation is dampening demand as merged entities eliminate engineering duplication and pivot toward internal resource utilization. * **Media & Telecom Strategy:** The company is selectively pursuing deal flow in these sectors, which is currently dominated by **cost-takeout and consolidation** opportunities. --- # 7. Guidance & Outlook ## A. Key Figures * **Growth Target:** **High-single-digit** FY27 exit rate (Revised from double-digit) * **PBT Margin:** **~27%** Target exit rate by Q4 * **Operating Margin:** **25.6%** Q4 FY26 · **27.0%** Q4 FY27 Target ## B. Growth Aspirations * **Revised Growth Outlook:** Management has moderated expectations to a high-single-digit trajectory due to geopolitical volatility, elongated decision-making cycles, and shifts in customer spending. * **Strategic Revenue Protection:** Focus is shifting toward large-scale efficiency deals to build a foundation of protected revenues, mitigating industry volatility until innovation cycles resume. * **New Growth Engines:** Significant results are anticipated within the next **four to six quarters** from emerging focus areas, specifically Aerospace & Defense, Battery Energy Storage, and Manufacturing. * **Segment Convergence:** Following a volatile 12-month period, the strategy for FY27 centers on achieving uniform growth across all three primary business verticals. ## C. Margin Targets * **Profitability Trajectory:** The company is targeting a return to its historical margin band of **27% to 28%** by leveraging operating efficiencies and financial leverage. * **Exit Rate Focus:** Margin expansion is being framed as a Q4 exit target rather than a full-year average, indicating a progressive improvement throughout the fiscal year. ## D. Vertical Recovery & Pipeline * **Healthcare Rebound:** Management identified Q4 as the cyclical bottom for the Healthcare & Life Sciences division, with a recovery projected for Q1 as high-probability deals from the funnel convert. * **Pipeline Visibility:** Current guidance is anchored by closed deals and existing pipeline visibility; however, management notes the trajectory remains sensitive to deal momentum shifts over the next **three to six months**.